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The  ability  of  living  and  killed  mycobacteria,  and  especially  of  tubercle 
bacilli and of certain of their crude fractions,  to affect the resistance of experi- 
mental  animals  to  heterologons  1 infections  (1-7)  and  to  tumor  transplants 
(8-10)  as well as  to homologous infection, i.e.  tuberculosis  (11-13),  has  been 
well established. 
In a number of these studies it appeared that certain fractions can induce a greater 
and more prolonged state  of heightened resistance  to homologous and beterologous 
challenges than does the intact bacillus. There is also some evidence that certain frac- 
tions can produce broad immunogenic effects without the concomitant development of 
grossly manifested  toxic reactions (5,  12-14) or  of tuberculin skin  hypersensitivity 
(5,13, 15). 
The beterologous immunogenicity of the tubercle bacillus is of considerable interest. 
Firstly, it points to the experimental, and conceivably also to the clinical,  use of this 
organism or of some of its moieties as broad enhancers of immune reactions, possibly 
beyond the scope of their already well known action as adjuvants to specific antigenic 
stimulation.  Secondly, it suggests the possibility of an interrelationship  between the 
mechanisms of acquired resistance  to tuberculosis and the enhanced resistance  to a 
large variety of other pathogenic microorganisms and tumor cells. The elucidation of 
the mode of action of the bacillus in one or more of the beterologous systems may thus 
also contribute to a better understanding of acquired resistance to tuberculosis. 
The immediate aim of future studies designed to clarify the relationship between the 
* Supported  by Research  Grant E-2309 from The National  Institute of Allergy and In- 
fectious Diseases, National Institutes of Health,  United States Public Health Service. 
l The words "heterologous"  and "homologous" will here be used in lieu of "non-specific" 
and "specific" in describing the direction of immunogenic effects. The latter terms have come 
to bear a connotation of mechanism as well as of direction and may, therefore, be misleading. 
Thus, a heterologously directed effect may involve such mechanisms as heightened ability to 
produce specific antibody, and homologously manifested changes may arise from non-specific 
mechanisms such as alterations in phagocytic power of RES cells. The question of appropriate 
terminology has also been discussed by Williams and Dubos (5). 
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homologous and heterologous immunological activities of the tubercle bacillus, and to 
cast light on their modes of action, should be the separation and characterization of 
the one or more active entities. This is a very formidable task, however, because of the 
chemical complexity of this organism, and because of the paucity of chemical or physi- 
cal markers of its immunological activities. Progress in this direction would be facili- 
tated by the availability of a partially purified parent fraction possessing a high and 
predictable degree of immunogenic activity, and free of toxic properties. Such a  ma- 
terial appears to have been obtained in the residue of BCG organisms killed by phenol, 
washed  with water  and acetone,  and extracted  exhaustively with absolute methyl 
alcohol. This residue possesses high protective activity against experimental tubercu- 
losis infections in mice (16) and guinea pigs (13), and is well tolerated by these animals. 
Its  heterologous  protective  activity  has  already  been  indicated  by  Dubos  and 
Schaedler (1), and confirmed in our laboratory (7, 9). 
The present report describes some of the conditions and parameters  of  the 
heterologous anti-infection activity of this substance, in comparison with that of 
living and intact phenol-killed BCG. 
Materials and Methods 
Experimental Design and Procedure.--Groups of mice were injected by the intraperitoneal 
or the subcutaneous routes with one of the tubercle bacillus substances or with sterile safine. 
Challenge infection was always intraperitoneally, unless otherwise  noted, with saline suspen- 
sions of young cultures of the pathogen to be tested. Different groups of mice were infected at 
different time intervals after treatment with the tubercle bacillus materials. The desired num- 
ber of organisms in the challenge inoculum  was calculated from turbidimetric readings of dilu- 
tions of the cultures, with reference to previously established curves relating optical density to 
viable bacterial count. Groups of normal animals were infected in each experiment to confirm 
experimentally the LDs0 of the cultures employed at each challenge time, as calculated by the 
Reed-Muench method. Deaths  were  recorded  daily, and sample autopsies were performed. 
Massive infection and disease attributable to the experimental pathogen were seen in all ani- 
mals who succumbed and were subjected to postmortem examination. The experiments were 
terminated when no further deaths had occurred for several days and when all survivors ap- 
peared to be well. Autopsy examination of sample survivors killed at termination of the experi- 
ments revealed either no, or only a small number of self-contained, lesions. The main criterion 
of protection was the relative incidence of surviving animals in the several groups of each ex- 
periment; the relative duration of life of animals who did not recover from infection was also 
employed as an index of resistance. 
Animals.--With several exceptions indicated in the text or the tables, the experiments were 
carried out with Swiss albino mice, supplied by the Griggs  Small Animal Farm, San Jose, 
California. All animals employed for a given experiment were of the same age and sex, except 
where sex differences were studied. Unless otherwise  noted, the differently treated groups in 
each experiment always consisted of 10 mice. The diet consisted of standard mouse pellets and 
water, ad lib. 
Tubercle Bacillus Preparations.--The  preparation of phenol-killed tubercle bacilli and of 
methanolic extracts and residues has been described in detail elsewhere (12, 13). The BCG was 
grown for 4 weeks on bacto-Dubos medium (Difco Laboratories, Inc., Detroit) without tween, 
but with the addition of 1.5 per cent glycerol. The cultures were then killed by exposure to 2 
per cent phenol at room temperature for 18 to 24 hours. The phenol wa,~ removed by repeated DAVm  W.  WEISS,  ROSE  S.  BOIVHAG, AND  JAMES  A.  PARKS  55 
washings with distilled water and acetone, and the bacillary mass was air-dried at room tem- 
perature, ground in a  porcelain mortar, and stored over a  desiccant in the cold  (4°C) until 
used. The yield of phenol-killed, washed bacilli was approximately 0.35 gin, dry weight,  ~ per 
liter of medium. 
Continuous extraction with methanol at 55°C took place for 9,to 12 consecutive days, 6 to 8 
hours daily. The hot alcohol was removed from the mixture by decanting after extraction 
periods of 6 to 12 hours. Fresh quantities of alcohol were added after each period. The extrac- 
tion residue was dried in air at room temperature, and stored over a desiccant in the cold until 
used. 
To suspend the killed bacilli or the methanol extraction residue in an aqueous vehicle, ap- 
propriate quantities were first thoroughly ground by hand in a mortar with a small volume of 
saline, and then dispersed in a micro-Waring blendor or virtis stirring apparatus. The result- 
ing suspensions were still coarse. In order to prevent unequal distribution of the material to 
the animals of a  group as a result of the settling out of the larger particles in the vessels or 
syringe, the suspensions were thoroughly agitated by hand between each loading of the syringe, 
and the syringes were loaded with only as much material as one animal Was to receive. The 
suspensions were always employed within 24 hours of preparation, and usually within 3 hours, 
and were kept at 4°C in the interval between preparation and use. 
Bacterial Cultures.--The  strain of tubercle bacillus employed was BCG 793, obtained from 
The Henry Phipps Institute, Philadelphia. For use as a living vaccine, the organism was grown 
for 1 week on bacto-Dubos medium containing tween 80 and 1.5 per cent glycerol. 
The culture of Klebsidla pneumoniae was obtained from the departmental culture collection 
maintained by Miss A. Larson. The organism was isolated 7 years previously from a pulmo- 
nary lesion discovered at autopsy in an experimental monkey. The strain underwent a marked 
loss of pathogenicity early in the course of the present experiments. A virulent clone was again 
obtained after mouse passage. In order to have cultures of high and predictable virulence for 
the remaining course of the study, aliquots of an 18 hour culture 0f proven virulence were 
lyophllized and used in all subsequent trials. To start a new culture, the lyophilized material 
was resuspended in brain-heart infusion broth and grown at 37°C for 18 hours. These cultures 
proved to be fairly consistent in their mouse virulence in all subsequent experiments. The 
LD60, as determined for each Klebsidla experiment, ranged from 6 to 120 organisms. Females 
consistently appeared to be more resistant than males. The challenge dose is expressed for each 
experiment in terms of multiples of the LDs0, as determined for each sex at the time of that 
experiment. 
The strain of Staphylococcus aureus Smith was obtained through the courtesy of the Merck 
Institute for Therapeutic Research, Rahway, New Jersey. Challenge infection was performed 
with 18 hour cultures grown on brain-heart infusion medium. Very large numbers of this or- 
ganism were required to kill mice by intraperitoneal infection in the absence of a virulence en- 
hancer such as mucin. An inoculum of 0.5 cc of a ~0 dilution of a young culture had to be em- 
ployed to bring about death of most of the control animals. 
RESULTS 
Protection against Klebsiella Infection.--Klebsiella  infection was  chosen as a 
model for a  large part  of  the study because of the high degree of virulence of 
this organism for mice,  the ready reproducibility of lethal infection with very 
The weights of tubercle bacilins materials presented in the text and tables always refer 
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small numbers of the bacteria, and the rapid outcome of the infection in death or 
recovery. 
Short term vaccination  challenge intervals: A characteristic feature of the heter- 
ologous immunogenicity of the  Gram-negative endotoxins and  their lipopoly- 
saccharide (LPS) moieties is the occurrence of a  period of decreased resistance 
which  precedes  that  of  heightened  refractoriness  to  infection  (17).  It  was 
thought of importance to determine whether the tubercle bacillus methanol-in- 
soluble fraction acts in a similar biphasic manner. 
TABLE I* 
Protea3ve  Activity  of Methanol  Extraction  Residue  against  Klebsiella  lnfeaion.  Vaccination 
Challenge Interval: 0 to 3 Days$ 
Vaccine  Vaccinatiou challenge  Surviving animals 
(0.25 to 0.5 cc, i.p.)  interval 
Saline (controls) ............................ 
Methanol extraction residue, O. 10 mg ........ 
"  "  "  0.10  "  ........ 
"  "  "  o.so  "ll ....... 
"  "  "  0.10  "  ........ 
]gtt$° 
0§ 
o 
24 
48 
72 
ioer cot4 
8 
33 
87 
55 
60 
* Some of the data in this table is based on experiments performed by Dr. Myron W. Fisher 
working with our residue fraction in the Laboratories of Parke, Davis and Company, Detroit. 
Animals: CF-1 and Griggs Females, weighing  18 to 22 gin,  15  to 60 animals/group. 
Infection: 3 LDs0. 
§ Residue administered at time of challenge infection. 
U  This residue preparation had been stored in the cold for 1 year. 
It is seen from the 7 representative experiments depicted in Tables I  to VII 
that significant proportions of mice injected intraperitoneally with a  quantity 
of methanol extraction residue in the range of 0.1  to 1.0 mg always survived 
experimental infection with 3  to  16 LDs0  of  Klebsidla  carried  out  simulta- 
neously, or up to 10 days later? The optimum dosage of residue varied within 
this range from experiment to experiment, as did the maximum degree of sur- 
vival protection which was elicited by the most effective quantity. In addition 
to the survival protection, mice injected with the fraction who did not recover 
frequently survived for a longer period of time. 
A  negative resistance phase was not encountered. Mice infected at the time 
of vaccination or as early as 6 hours thereafter did not show a  heightened sus- 
ceptibility to infection,  as would have been  indicated by a  shorter  duration of 
life after infection. To the contrary, evidence of protection was already seen in 
these groups of animals (Tables I  and II). 
* Preliminary studies indicated that quantities of the fraction less than 0.1 mg or more 
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The peak of protective activity appeared to have been reached by 24 hours 
(Table I), and protection was still high at 10 days (Table VII). Protection was 
manifested against fairly severe, i.e.  >  10 LDs0, as well as against lighter, i.e. 
<  5  LD~o, infections  (Tables III  to VII).  The  subcutaneous  route of vaccina- 
tion was ineffective under  the conditions of these experiments, as illustrated by 
the  results shown  in  Table  V.  (Subcutaneous  vaccination  was found  effective 
against a  proximally placed subcutaneous  challenge inoculation; reference  18.) 
Females  accured  greater  protection  from  the  residue  pretreatment  than  did 
TABLE  II 
Protective Activity of BCG Fractions against Kleb~iella Infection.  Vaccination  Challenge Interval: 
6 Hours and 3 Days* 
Vaccine 
(in  0.5 cc, i.p.) 
Saline (controls) ....................................... 
Living BCG, 1/10 dilution of a  7-day-old culture .......... 
"  "  1/5  "  "  "7  "  "  "  .......... 
Phenol-killed BCG, 0.1  mg  ............................ 
"  "  "  0.25  "  ............................ 
"  "  "  0.50  "  ............................ 
"  "  "  1.0  "  ............................ 
Methanol extraction residue, O. 1  mg .................... 
"  "  "  0.25  "  .................... 
"  "  "  0.50  "  .................... 
"  "  "  1.0  "  .................... 
No. of surviving animals when 
vaccination challenge interval was 
6 hrs.  3 days 
0  1 
0  0 
0  0 
1  1 
0  0 
4  0 
1  1 
0  0 
0  0 
3  5 
5  1 
* Animals: 5-week-old females, 10 animals/group. Infection: 15 LD~o. 
TABLE  IH 
Protective  Activity  of Methanol  Extraction  Residue  against  Klebsidla  Infection.  Vaccination 
Challenge Interval:  3 Days* 
Vaccine 
(0.5 ce, i.p.) 
Saline (controls) ............................ 
Methanol extraction residue, O. 25 mg ......... 
"  "  "  0.50  "  ......... 
"  "  "  1.0  "  ......... 
No. of surviving animals when  challenge was with 
4 LDto  16 LDlo 
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males (Tables IV and VI). Storage of the material over a  desiccant in the cold 
for as long as a year did not destroy activity  (e.g. Table I).  Living BCG offered 
no protection (Tables II, V, and VIII). 
Duration  of  the  anti-Klebsiella  protection:  Whereas  some degree  of  survival 
TABLE  IV 
Protective  Activity  of Methanol  Extraction  Residue  against  Klebsiella  Infection.  Vaccination 
Challenge Interval:  3 Days* 
Vaccine 
(0.5 cc., i.p.) 
Saline (controls) ........................... 
Methanol extraction residue, 0.25 mg ........ 
"  "  "  0.50  "  ........ 
"  "  "  1.0  "  ........ 
No, of surviving animals when challenge  was with 
4 LD60  14 LDs0 
Males  Females 
0  1 
2  3 
5  7 
6  9 
Males  Females 
0  1 
0  2 
2  6 
6  8 
* Animals: 5-week-old, 10 animals/group. 
TABLE  V 
Protective  Activity  of Methanol  Extraction  Residue  against  Klebsidla  Infection.  Vaccination 
Challenge Interval:  4 Days* 
Vaccine 
(O.S  cc) 
Saline (controls) ..... ................................... 
Living BCG, 1/50 dilution of a 7-day-old culture ........... 
Methanol extraction residue,  0.4 mg ...................... 
"  "  "  0.8  "  ...................... 
No. of survlvin~[  animals 
when vaccinatlon was 
i.p.  s.c. 
4 LDso  13 LD~ 
1  1 
0  0 
2  1 
5  7 
4 LD6o  13 LD~o 
1  1 
0  1 
0  0 
* Animals: 5-week-old females,  10 animals/group. 
protection was  invariably elicited by  the  methanol-insoluble residue  against 
Klebsiella  infection for a  period up to  10 days,  the results of longer term pro- 
tection studies were not consistent. In our hands, the material proved ineffec- 
tive  on some  occasions in bestowing  heightened  resistance  against Klebsiella 
infection carried out 11 or more days after vaccination, but definitely effective 
at other times (e.g.  Table VIII). No explanation for this inconsistency has yet 4  ~  .,  ':  "  7.'." 
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offered itself. Working with our fraction at the laboratones of Parke, Da~s~  : ";~r ~ 
........ ~A  ~,t  '  Company m  Detroit, Dr. M. W. Fisher s~mflarly found that protective actl~nt~  .~  •  ~g 
diminished after  1  week,  although  a  negative  resistance phase  did not  then 
occur (18). In contrast, the same substance tested by Dr. Florence Fitzpatrick 
TABLE VI 
Protective  Activity  of Methanol  Extraction  Residue  against  Klehsiella  Infection.  Vaccination 
Challenge Interval:  4 Days* 
No. of surviving  animals when challenge  was  with 
4 LD~o  16 LDso 
Females 
Vaccine 
(0.5 cc,  i.p.) 
Males 
Saline (controls)  ...........................  0 
Methanol extraction residue, 0.25 mg ........  0 
"  "  "  0.50  "  ........  2 
"  "  "  1.00  "  .......  3 
Males  Females 
t  --  -- 
I  1  o 
0  1 
1  1 
2  5 
* Animals: 5-week-old, 10 animals/group. 
TABLE VII 
Protective  Acridly  of Methanol  Extraction  Residue  against  Klebsidla  Infection.  Vaccination 
Challenge Interval:  3 and 10 Days* 
Vaccine 
(0.5  cc.,  i.p.) 
Saline (controls) ............................. 
Methanol extraction residue, 0.25 mg ......... 
"  "  "  0.50  "  ......... 
"  "  "  1.0  "  ......... 
No. of surviving animals when vaccination 
challenge interval was 
3 days  10 days 
3 LDso  12 LDso  3 LD~ 
1 
1 
9 
5 
12 LD6o 
2  2 
5 
4 
1 
* Animals: 5-week-old females, 10 animals/group. 
at the Merck Institute for Therapeutic Research was found effective even at 
the longest vaccination challenge interval tested, 4 months (Table IX) (19). 
Even when the residue preparation was scored as giving "no protection" in 
one of our experiments on the basis of the chief criterion, recovery from infec- 
tion,  some  resistance-enhancing  effect was  frequently  still discernible in  the 
longer postinfection life of treated animals•  This is illustrated by the  experi- 60  HETEROLOGOUS  IMMUNOGENICITY.  I 
ments presented in Tables X  A  and X  B. In the experiment presented in Table 
X  A, pretreatment of the animals did not result in significant differences in the 
incidence of recovery following infection 11 days later. In the experiment shown 
in Table X  B, 5 of 10 animals recovered from a very heavy infection,  18 LD~0, 
TABLE VIII 
Protective Activity  of Methanol Extraction  Residue  against Klebsidla  Infection.  Duration 
of Protection* 
No. of surviving animals when 
vaccination challenge 
Vaccine  interval was 
(0.5 cc., i.p.) 
1day  3days  9days  27 days 
Saline (controls) .........................................  1  1  0  0 
Living BCG, 1/10 dilution of a 7-day-old culture ............  0  0  0  2 
Methanol extraction residue, 1.5 mg  ......................  .  15  13  6  9 
* Animals: 8-week-old males, 16 animals/group.  Infection: 4 LD~0. 
TABLE IX* 
Protective Activity of Methanol Extraction Residue against Klebsidla Infection. 
Duration of Protection~ 
No. of surviving animals out of total when vaccination (i.p.) was with 
following quantities of methanol extraction residue  Vaccination challenge 
interval 
0.5 mg  0.25 mg  Ct mg (Saline controls) 
days 
2  m/to  9/10  1/20 
7  9/10  7/10  1/10 
15  9/10  7/10  3/10 
28  --  10/10  3/10 
60  --  8/lo  o/lo 
120  --  6/10  0/20 
* This table is base~ on data obtained at the Merck Institute for Therapeutic  Research 
by Dr. Florence Fitz)atrick working with our residue fraction, and is presented here by her 
kind permission. 
:~ Animals: CF-1 females weighing 16 to 18 gin. Infection: 1 LDT0 to LDtoo per mouse. 
in the  1.0 nag residue group, and only 1 animal in the 0.5 mg group. In both 
experiments,  however,  the  animals  in groups showing no survival protection 
lived longer than the saline-treated controls. 
It should be mentioned in passing that the protective efficacy of small quan- 
rifles of the fraction against tumor isografts consistently maintained itself for 
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Protection  Induced against  Other Strains of Klebsidla and against  Other Bac- 
terial Patkogens.--All three tubercle bacillus preparations tested,--living BCG, 
intact phenol-killed bacilli,  and methanol extraction residue,--induced  signifi- 
cant survival protection against staphylococcal infection performed 3  and  14 
days after vaccination (Table XI). Marked protection was also bestowed by 
TABLE X  A 
Proteztive Activity of Methanol Extraction Residue against Klebsioga Infection. Vaccination 
Challenge Interval: 11 Days* 
Cumulative no. of animals dead at following 
Vaccine  times after infection, days 
(0.5  cc., i.p.) 
2  3  4  5  6  7 
Saline(controls) .................................  013  9  lO  I 
Methanol extractionresidue,  0.25 mg ..............  0  [  0  [  2  [  4  8  8 
......  1.o  ".  .............  0  10  I  2  I  4  I  7  t  8 
* Animals: 5-week-old  males, 10 animals/group. Infection: 4 LD~o. 
TABLE X  B 
Protective Aalvity  of Methanol Extraction Residue against Klebslella Infeaion.  Vaccination 
Challenge Interval: 3 Days* 
Vscclne 
(0.5 cc., i.p.) 
Saline (controls) ............................ 
Methanol extraction residue, O. 25 nag ......... 
"  "  0.50  ........ 
"  "  "  1.0  "  ........ 
Cumulative no. of animals dead at following 
times after infection, days 
0  1 
o  o 
o  o 
o  o 
3  4 
-T  3 
12 
0J2 
0  0 
i 
5 
lO 
5  7 
5  5 
2  3 
?  8 
8  8 
8  8 
4  4 
IO  13 
8  8 
4  5 
19 
* AnimaLs: 5-week-old  females, 10 animals/group. Infection: 18 LDso. 
the residue  fraction against five other bacterial pathogens  (Table XII), and 
against three other strains of Klebsiella pneumoniae (Table XIII). 
Protection  against  a Naturally Occurring dPneumonitis.--Mice maintained in 
the animal quarters of the Cancer Research Genetics Laboratory (CRGL) are 
occasionally subject to outbreaks  of pneumonitis.  A  low level of infection is 
encountered frequently in the colonies, especially among very young and very 
old animals. The etiological agent appears to be a virus (20). 
It was noticed on several occasions that the mice in certain cages remained 
free of symptoms of the disease during epidemics which involved all other ani- 62  HETEROLOGOUS  IMMUNOGENICITY.  I 
TABLE  XI 
Protective  Activity  of BCG  Fractions  against  Staphylococcus  Infection.  Vaccination  Challenge 
Interval: 3  and 14 Days* 
Vaccine 
(0.5 cc., i.p.) 
Saline (controls) ......................................... 
Living BCG,  1/2  dilution of a  7-day-old culture ............ 
No. of surviving animals when 
vaccination challenge 
interval was 
3 days  14days 
3  0 
7  5 
"  "  1/5  "  .... 7  ..... '  ............ 
"  "  1/10  "  "  "7  "  "  "  ............ 
Phenol-killed BCG,  0.25 mg ...................... 
"  "  "  0.50  "  ...................... 
"  "  "  1.0  "  ...................... 
Methanol extraction residue 0.25 mg ...................... 
"  "  "  O. 50  "  ...................... 
"  "  "  1.0  "  ...................... 
7 
10 
9 
7 
10 
10 
10 
9 
5 
7 
10 
* Animals: 6-week-old males, 10  animals/group. Infection: 0.5 cc of a  1/10 dilution of an 
18 hour culture. 
TABLE  XlI* 
Protective Activity of Methanol  Extraction  Residue against  Several Bacterial Infections. 
Vaccination  Challenge Interval:  4  days~ 
Challenge organism 
(administered i.p.) 
Streptococcus  pyogenes ........................ 
Diplococcus  pneumoniae ...................... 
Staphylococcus  aureus§ ....................... 
Proteus mirabilis§ ........................... 
Pseudomonas  aeruginosa§ ..................... 
Salmonella  typhimurium ....................... 
Survivors in animals pretreated with 
SaLine 
(controls), i.p. 
per cenl 
4O 
13 
7 
0 
13 
7 
Methanol extraction 
residue, 0.5 nag, i.p, 
pet" Cent 
73 
73 
93 
100 
03 
27 
* This table is based on data obtained  in the laboratories of Parke,  Davis and Co., De- 
troit,  by Dr. Myron W. Fisher working with our residue fraction, and is here presented by 
his kind permission. 
2~ Animals: CF-1 females, weighing 18 to 22 gm, 20 animals/group. Infection: 2 to 8 LDs0. 
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mals originating from the same litters. Upon decoding the identifying ciphers 
of the protected cages, it was found that the unaffected animals had always re- 
ceived prior injections of  methanol extraction residue. An experiment was de- 
signed to confirm this observation. 
The experiment was conducted at a time when the incidence of pneumonitis was approxi- 
mately 20 per cent among young animals in the CRGL colony. 60 apparently healthy BALB/ 
c/Crgl virgin females, 2 to 4 months old, were divided randomly into two equal groups. One 
received a single intraperitoneal  injection of 0.5 mg methanol extraction residue in 0.25 cc 
saline, and the other remained untreated. The two groups were housed in separate cages, but 
TABLE XlII* 
Protective  Activity of Methanol Extraction Residue against  3 Other Strains of Klebsidla. 
Vaccination  Challenge  Interval: 4 Days~ 
Vaccine 
(0.25 cc., i.p.) 
Saline (controls) ............................... 
Methanol extraction residue, O. 20 mg ............ 
"  "  0.50  ........... 
"  "  "  1.0  "  ........... 
No. of surviving animals infected with 
3 LDso of  Klebsidla strains 
MGH-I§ 
6 
9 
10 
18 
MGH-2  AD 
0  3 
2  13 
2  2O 
11  20 
* This table  is based on data obtained  in the laboratories of Parke,  Davis and Co. by 
Dr. Myron W. Fisher working with our residue fraction, and is here presented by his kind 
permission. 
:~ Animals: CF-1 females, weighing 18 to 22 gin, 20 animals/group. 
§ The strain designations refer to Dr. Fisher's culture collection. 
in close proximity in the same room. 3 weeks later, all animals were mated with seemingly 
healthy  BALB/c/Crgl  males. Careful  records were kept  of  the  breeding  behavior  of 
the mothers and of the appearance and fate of the young of the first litters until weaning, at 
the age of 5 weeks. The cages in which the animals were housed were labeled in code and dis- 
tributed at random in the quarters; the personnel making the observations could not identify 
the treatment groups. The results are presented in Table XIV. 
It is seen from Table XIV that the number of litters borne by the treated 
group was somewhat greater than that by the controls. The number of animals 
per litter, and their birth weights, were the same. Considerably fewer offspring 
of treated mothers were in generally poor  condition,---small size,  ruffed  fur, 
hunched posture,--or showed the more specific symptom of pneumonitis, the 
presence of detectable rales. (Most animals in our colony who are sacrificed and 
examined subsequent to the development of rales exhibit the typical lesions of 
viral pneumonitis.) More offspring of untreated mothers died of undiagnosed 64  HETEROLOGOUS  r~n~rUNOGEMCITY.  I 
causes (of which a  large proportion probably involved pneumonitis as a major, 
if not as the only, cause)  before weaning,  and  the average weight of the sur- 
vivors at weaning was less. 
The mothers in both  groups appeared well during  this observation period, 
but it must be noted that frank symptoms of pneumonitis may be absent in 
adult mice for periods of time despite extensive pathologic involvement of the 
lungs. 
TABLE XIV 
Effezt  of Administration of Methanol  Extraction  Residue  on the Breeding Behavior of Female 
Mice (BALB/c) and on the Health and Survival of Tkeir Offspring 
(First Postvaccination Litters) 
No. of litters  ........................... 
No. of young born ...................... 
Average weight of young at birth .......... 
No. of young in generally poor condition... 
No.  of young with apparent pneumonitis 
(rales) ............................... 
No. of young who died before being weaned.. 
No. Weaned ............................. 
Average weight of young at weaning ....... 
Prepregnancy treatment of mothers* 
None (controls) 
13 (43.3 per cent) 
74 (5.7/fitter) 
3.1 gm 
11 (14.8 per cent) 
13 (17.5 per cent) 
17 (22.9 per cent) 
57 (77.1 per cent) 
14.7 gm 
0.5 mg methanol extrac- 
tion residue,  i.p., 3 weeks 
before onset of pregnancy 
19 (63.3 per cent) 
111 (5.8/litter) 
3.1 gm 
5  (4.5 per cent) 
1  (0.9 per cent) 
9  (8.1 per cent) 
102 (91.9 per cent) 
15.9 gm 
* 30 mothers in each group. 
A second experiment was designed to ascertain the repeatability of the observations,  and 
the duration of the beneficial effect of the tubercle bacillus fraction on the breeding behavior of 
the mothers and on the condition of the young. 152 apparently healthy, 3-month-old BALB/c/ 
Crgl females were divided into two equal groups. One received a single intraperitoneal injec- 
tion of 0.5 mg methanol extraction residue in 0.25 cc saline, the other saline alone. The animals 
were then placed into normal breeding production for a period of 10 months. The number of 
litters born during the 11th month, and the number and appearance  of the weanlings, were then 
carefully observed and recorded. As in the previous experiment, the animals were housed in 
coded, randomly distributed cages. The observations are presented in Table XV. 
As seen from Table XV,  only 38  of the 76 breeding females in each group 
were  still alive 9  months  after the  treatment with  saline or with  the residue 
fraction. As these animals were not observed daily during the 10 months after 
treatment, only a  few of the cadavers could be recovered in a  condition which 
made autopsy examination feasible. The cause of the high death rate in both 
groups could not,  therefore,  be ascertained with certainty. The results of the 
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pneumonitis in the quarters at that time, make it appear likely that this in- 
fection played a large role in the mortality. 
A marked difference was seen in the number of control and vaccinated animals 
who gave birth: Only 10 of 38 (26.3 per cent) control animals had fitters in the 
llth month, as against 27 of 38 (71.1 per cent) in the vaccinated group.  The 
number of young per fitter who survived to weaning was similar, but the per- 
eentage of those scored as being in generally poor  condition at weaning was 
almost three times greater in the control group. 
TABLE XV 
Effect of Administration of Methanol Extraction Residue to Female Mice  (BALB/c)  on the 
Breeding Behavior of the Mothers and on the Appearance of Their Offspring at 
Weaning (Litters Born in lltk Postvaccination Month) 
No.  of  surviving  females  9  months  after 
treatment ............................ 
No. of litters ............................ 
No. of young at weaning~ ................ 
No. of young in poor condition at  time of 
weaning§  ............................. 
Prepregnancy treatment o[ mothers* 
Saline  (controls) 
38 (50 per cent) 
10 (26.3 per cent) 
35 (3.5/litter) 
7 (20 per cent) 
0.$ mg methanol 
extraction residue, i.p. 
38 (50 per cent) 
27 (71.1 per cent) 
107 (4.0/litter) 
8  (7.5 per cent) 
* 76 mothers in each group. 
:~ Records of litter size at birth, and deaths before weaning, were accidentally lost. 
§ Many of the animals scored as being in poor condition exhibited the typical rales as- 
sociated with pneumonitis disease. 
If it may be assumed that the major reservoir of pneumonifis as well as of 
many other infections  of mice during the first weeks of life is maternal,  ~ the 
superior condition of the young of treated mothers could be explained as arising 
from a heightened resistance on the part of the mothers to the infection or to 
those of its pathologic  developments  which result in the shedding  of the in- 
fectious agent.  It  is  also  conceivable  that  the  young acquire  through  the 
mother's milk  some  resistance-enhancing  factor(s)  induced by the  tubercle 
bacillus fraction. Experiments are in progress to clarify the nature of the pro- 
tective effect. 
4 Support for this assumption comes  from  the repeated observations in our breeding colony 
that the incidence of pneumonitis is much higher in young of mothers who show frank clinical 
symptoms of the disease before and after giving birtht or in whom histological evidence of 
pneumonitis  is  found  upon  sacrifice and  postmortem  examln~tion,  than  it  is  in  young 
of mothers free of both clinical and histological evidence of the infection. 66  HETEROLOGOUS  IM2~UNOGENICITY.  I 
DISCUSSION 
There  exist a  number  of similarities in  the  biological properties  of Gram- 
negative endotoxins and their lipopolysaccharide fractions, and tubercle bacilli 
and some of their crude, partly defatted moieties. 
Notable among these is the ability of both classes of materials to act as immunologi- 
cal adjuvants (21, 22), to stimulate reticuloendothelial  function (23, 24), to act in the 
Shwartzman phenomenon (25), to broadly affect antimicrobial immunity (1-7, 17, 26), 
and to induce a state of resistance to the take and growth of tumor transplants (8-10, 
26, 27). Similarity of the chemical composition of the immunogenically active fractions 
of Gram-negative bacteria and of tubercle bacilli has also been postulated (5, 28).  The 
present study describes the heterologous antimicrobial immunogenicity of one tubercle 
bacillus fraction, the methanol extraction residue, but also points to important dilfer- 
ences between its activity and that of the endotoxins. 
Unlike the endotoxins and their LPS moieties, the tubercle bacillus fraction does not 
bring about a period of lowered heterologous  resistance shortly after administration, 
and antecedent to the phase of heightened resistance.  Although maximum heterologous 
protection was seen only after approximately 24 hours, definite evidence of a protective 
effect could be detected even when experimental infection  took place simultaneously 
with, or 6 hours after, treatment. 
Schaedler  and Dubos did report that administration of a similar methanol extrac- 
tion residue  3 hours before infection with  staphylococci hastened the death of mice 
(29), but this effect was observed by them only when a quantity of 5 mg of the ma- 
terial was used, approximately five times the optimally effective dose in our experience. 
Quantities of tubercle bacillus fractions several times in excess of the optimum im- 
munogenic amounts (which should  be ascertained empirically for a given batch of the 
material, and for a given test system) have also been found by us to exert a slightly 
deleterious influence on resistance to tumor isografts (14). As is true for large amounts 
of very many bacillary substances (12, 30), excessive quantities of methanol extraction 
residue undoubtedly will also produce toxic effects, and any interpretation of the na- 
ture of the "resistance-depressing"  properties of large quantities must consider  the 
ready possibility of an additive or synergistic action between the effects of infection 
and a preexisting state of toxicity and debilitation. In no instance was intraperitoneal 
administration of the residue  to mice in the range here tested,-- 0.1  to 1.5 mg dry 
weight,--accompanied by any gross manifestations of toxicity; the rate of weight gain 
and the appearance of the animals remained normal 04). 
The residue  fraction also proved capable of eliciting heterologous  immunogenieity 
of considerable  duration. Although a state of protection exceeding a period of 10 days 
could not be demonstrated in every experiment, it was frequently observed for periods 
as long as 4 months, and, in the tumor systems (14), longer. The reasons for the lack of 
consistency in the results of long term protection studies remain to be investigated. 
The optimum dosage of the protective fraction must be expressed in relation 
to the challenge organisms. This is exemplified by the data presented in Table 
XIII. As little as 0.2 mg offered significant protection against infection with the 
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0.5 mg offered maximal protection against AD, none against "MGH-2," and 
little against "MGH-1;" 1.0 mg sufficed to protect 18/20 mice against MGH-1, 
but only 11/20 against MGH-2. This relationship of dosage to the strain of the 
pathogen employed has been noted in other, unpublished trials.  The effect of 
dosage of the fraction was frequently seen to be influenced  as well by other, 
also  interrelated  experimental  variables,  notably  route  of  vaccination  and 
challenge,  severity of challenge  infection,  and length of vaccination challenge 
interval. 
Most investigators  who have studied the heterologous immunogenicity of 
tubercle bacilli have employed living  BCG as the immunizing  stimulus. The 
present results show that the methanol extraction residue of phenol-kiUed BCG 
offers heterologous protection even under experimental conditions when living 
BCG is ineffective.  This has also been observed in the antitumor  protection 
studies (9, 14). The desirability of certain fractions of the tubercle bacillus for 
employment as antituberculosis vaccines,--on the grounds of safety, tuberculin 
non-allergenicity,  ease of standardization and administration, and, in the hands 
of some investigators, superior protective ability,--has already been discussed 
(11).  A fraction  of the tubercle bacillus is here  seen to be immunogenically 
superior to the living organism in a heterologous system as well. Intact, killed 
tubercle bacilli were not subjected to sufficient  study in these experiments to 
permit  a  comparative statement.  Where they were tested together with the 
residue fraction, they were found to be effective,  but not more so. However, 
intact phenol-killed  BCG produces a  much greater degree of tuberculin skin 
hypersensitivity, and is less well tolerated, on a  weight-to-weight basis, than 
the fraction (13). 
None of the presently reported experiments  provides information  directly 
pertinent  to an understanding  of the mode of action of the heterologous im- 
munogenicity of the methanol-insoluble fraction. Experiments in this direction 
will be described in a forthcoming communication  (31).  It might be noted in 
passing that the greater efficacy of the fraction in females than in males might 
arise from mechanisms similar  to those responsible for the greater inhibitory 
effect of BCG infection in female mice against  transplants  of carcinogen-in- 
duced  cancers  (8).  Old  et  al.  advanced  the  tentative  explanation  that  the 
greater antitumor protection bestowed on female animals may be related to the 
fact that females "respond more vigorously than males to bacterial  products 
which induce a proliferative reaction of the RES"  (8)) 
SUMMARY 
Small  quantifies of the non-toxic residue of phenol-killed,  acetone-washed, 
and methanol-extracted  tubercle bacilli  of the BCG strain  conferred a  high 
8  On the other hand, Gledhill and Rees (6) found that a  mycobacterial  infection offered 
some protection to males, but not to females, against ectromeiia. 68  HETEROLOGOUS IMMUNOGENICITY. I 
degree of resistance on mice against  otherwise lethal  experimental infection 
with Klebsiella pneumoniae and with a number of other pathogenic bacteria. 
The heightened resistance reached a peak within 24 hours after administra- 
tion  of  the  fraction,  but  was  already  discernible immediately thereafter. A 
period of reduced resistance was not observed. The state of heightened resist- 
ance was invariably manifested for at least 10 days, and could frequently still 
be demonstrated after several weeks or months. The methanol-insolublefraction 
was immunogenieally active even in experimental circumstances under which 
living BCG exerted no effect. Its protective effect was more marked in females 
than in males. The optimum dosage must be determined empirically ~is-d-vis 
the strain of infecting organisms and the experimental parameters of adminis- 
tration and testing. 
Administration of the fraction to breeding females reduced the incidence of a 
naturally occurring endemic pneumonifis among  their young,  and  increased 
considerably the breeding productivity of the mothers. These effects were mani- 
fested as late as 11 months after treatment. 
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